HomeNewsBusinessCoronavirus-led layoffs | People + Work Connect, a platform to connect laid off employees with companies

Coronavirus-led layoffs | People + Work Connect, a platform to connect laid off employees with companies

The analytics-driven platform, People + Work Connect, was designed by Chief Human Resources Officers from Accenture, Lincoln Financial Group, ServiceNow and Verizon

April 14, 2020 / 21:30 IST
Story continues below Advertisement

At a time when retrenchments are becoming a norm as enterprises are bracing to tackle novel coronavirus and cut costs, Accenture, along with multinationals, has built a platform to connect companies that are laying off employees and the ones who are in need of workers.

The analytics-driven platform, People + Work Connect, was designed by Chief Human Resources Officers from Accenture, Lincoln Financial Group, ServiceNow and Verizon, according to a press statement.

Story continues below Advertisement

There is no cost for employers to join and participate, the statement added.

The platform, which is global and cross-industry, gives real time visibility about which companies need people and where. For collecting the information, it uses non-confidential and aggregated workforce information by categories such as location and experience, the statement said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show